Browsing Peninsula Medical School by Author "ae174c28-4b85-4bd3-8b3b-c47e953d2f9f"
Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials Brown, JR; Moslehi, J; O’Brien, S; Ghia, P; Hillmen, P; Cymbalista, F; Shanafelt, TD; Fraser, G; Rule, S; Kipps, TJ; Coutre, S; Dilhuydy, M-S; Cramer, P; Tedeschi, A; Jaeger, U; Dreyling, M; Byrd, JC; Howes, A; Todd, M; Vermeulen, J; James, DF; Clow, F; Styles, L; Valentino, R; Wildgust, M; Mahler, M; Burger, JA (Ferrata Storti Foundation (Haematologica), 2017-10)
Improvement of fatigue, physical functioning, and well-being among patients with severe impairment at baseline receiving ibrutinib in combination with bendamustine and rituximab for relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma in the HELIOS study. Cramer, P; Fraser, G; Santucci-Silva, R; Grosicki, S; Dilhuydy, M-S; Janssens, A; Loscertales, J; Rule, S; Goy, A; Traina, S; Chan, EKH; Diels, J; Sengupta, N; Mahler, M; Salman, M; Howes, A; Chanan-Khan, A (Taylor & Francis, 2018-01-03)Health-related quality of life (HRQoL) is an important endpoint, especially in clinical trials for malignancies with a long course of disease, such as chronic lymphocytic leukemia (CLL). Patient-reported outcomes were ...